Ependymoma - 48 Studies Found
| Completed |
: Adult Intracranial Ependymoma : Intracranial Ependymoma : 2009-05-04 : Other: tumoral sample Ependymoma tumoral sample |
| Completed |
: Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma :
: 2011-12-21 : Drug: 5-fluorouracil 5-fluorouracil, bolus dose of 500 mg/m^2 given weekly for 4 weeks followed by a two |
| Terminated |
: Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205 : Ependymoma : 2010-11-23 : Drug: Erlotinib continuous oral Erlotinib 85 mg/m^2 per day |
| Completed |
: Study of Tumor Samples From Patients With Ependymoma Treated on the Children's Oncology Group ACNS0121 Trial :
|
| Recruiting |
: Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma :
|
| Recruiting |
: Feasibility Trial of Optune for Children With Recurrent or Progressive Supratentorial High-Grade Glioma and Ependymoma :
: 2017-01-17 : Device: Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields) The Optune, a.k.a. Tumor Tr |
| Recruiting |
: Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Children With Recurrent Posterior Fossa Ependymoma : Brain Tumor Recurrent : 2016-10-18 : Drug: 5-Azacytidine 5-Azacytidine 10 mg into the fourth ventricle of the brain via the Ommaya reservoir |
| Completed |
: Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, CNS-PNET or Ependymoma :
|
| Completed |
: High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma : Brain and Central Nervous System Tumors : 2006-02-06 :
|